These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 5774870)
1. Suppression of bacteriuria by methenamine mandelate in aged hospital patients with chronic disease. Bohensky FB J Am Geriatr Soc; 1969 Apr; 17(4):394-6. PubMed ID: 5774870 [No Abstract] [Full Text] [Related]
2. Treatment with methenamine hippurate in the patient with a catheter. Norrman K; Wibell L J Int Med Res; 1976; 4(2):115-7. PubMed ID: 1026540 [TBL] [Abstract][Full Text] [Related]
3. [Clinical testing of methenamine hippurate (Hiprex) in the treatment of urinary tract infections]. Bengtsson U; Orsten PA Lakartidningen; 1973 Dec; 70(49):4517-9. PubMed ID: 4595775 [No Abstract] [Full Text] [Related]
4. Lack of effect of methenamine in suppression of, or prophylaxis against, chronic urinary infection. Vainrub B; Musher DM Antimicrob Agents Chemother; 1977 Nov; 12(5):625-9. PubMed ID: 921259 [TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of chronic urinary tract infections. A comparative study of four drugs. Taneja OP; Grover NK; Gulati SM; Ao NK; Bhatia VN Indian J Med Sci; 1974; 28(4-5):197-207. PubMed ID: 4435926 [No Abstract] [Full Text] [Related]
6. Prevention of recurrent urinary tract infection with methenamine mandelate. Keswani RK; Chugh TD; Hooda RS; Beniwal JS Indian J Med Res; 1976 Aug; 64(8):1168-72. PubMed ID: 992846 [No Abstract] [Full Text] [Related]
7. Long-term therapy for chronic bacteriuria in men. U.S. Public Health Service cooperative study. Freeman RB; Smith WM; Richardson JA; Hennelly PJ; Thurm RH; Urner C; Vaillancourt JA; Griep RJ; Bromer L Ann Intern Med; 1975 Aug; 83(2):133-47. PubMed ID: 1096704 [TBL] [Abstract][Full Text] [Related]
8. Methenamine hippurate in urinary tract infections in children: prophylaxis, treatment and side effects. Elo J; Sarna S; Ahava K; Lepo A J Antimicrob Chemother; 1978 Jul; 4(4):355-65. PubMed ID: 690036 [No Abstract] [Full Text] [Related]
9. Continuous chemotherapy in the prevention of recurrent bacteriuria. Lancet; 1969 Feb; 1(7588):248. PubMed ID: 4178600 [No Abstract] [Full Text] [Related]
10. Rational use of methenamine mandelate. Gabrielson RM Am J Hosp Pharm; 1979 Dec; 36(12):1658-9. PubMed ID: 525640 [No Abstract] [Full Text] [Related]
11. Predictability of methenamine efficacy based on type of urinary pathogen and pH. Nahata MC; Cummins BA; McLeod DC; Butler R J Am Geriatr Soc; 1981 May; 29(5):236-9. PubMed ID: 7014695 [TBL] [Abstract][Full Text] [Related]
12. Decreased incidence of urinary tract infections in patients with spinal cord injury: effect of methenamine. Banovac K; Wade N; Gonzalez F; Walsh B; Rhamy RK J Am Paraplegia Soc; 1991 Apr; 14(2):52-4. PubMed ID: 2051157 [TBL] [Abstract][Full Text] [Related]
15. Controlled trial comparing co-trimoxazole and methenamine hippurate in the prevention of recurrent urinary tract infections. Kalowski S; Nanra RS; Friedman A; Radford N; Standish H; Kincaid-Smith P Med J Aust; 1975 May; 1(19):585-9. PubMed ID: 1152707 [TBL] [Abstract][Full Text] [Related]
16. A comparative trial of hexamine hippurate and hexamine mandelate in prevention of recurrent infection of the urinary tract. Gow JG Practitioner; 1974 Jul; 213(1273):97-101. PubMed ID: 4280569 [No Abstract] [Full Text] [Related]
17. Editorial: A clinical classification of urinary tract infections based upon origin. Stamey TA South Med J; 1975 Aug; 68(8):934-9. PubMed ID: 1099658 [No Abstract] [Full Text] [Related]
18. [Methenamine hippurate in urinary tract infections]. Klein D; Puchegger R ZFA (Stuttgart); 1976 Jul; 52(21):1110-4. PubMed ID: 785852 [No Abstract] [Full Text] [Related]
19. Lack of effect of ascorbic acid, hippuric acid, and methenamine (urinary formaldehyde) on the copper-reduction glucose test in geriatric patients. Nahata MC; McLeod DC J Am Geriatr Soc; 1980 May; 28(5):230-3. PubMed ID: 7365188 [TBL] [Abstract][Full Text] [Related]